BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19857032)

  • 1. Omega-3 fatty acids and cardiovascular disease risk: do we understand the relationship?
    Vrablík M; Prusíková M; Šnejdrlová M; Zlatohlávek L
    Physiol Res; 2009; 58 Suppl 1():S19-S26. PubMed ID: 19857032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary omega-3 fatty acid intake and cardiovascular risk.
    Psota TL; Gebauer SK; Kris-Etherton P
    Am J Cardiol; 2006 Aug; 98(4A):3i-18i. PubMed ID: 16919512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acid supplementation and cardiovascular disease.
    Jump DB; Depner CM; Tripathy S
    J Lipid Res; 2012 Dec; 53(12):2525-45. PubMed ID: 22904344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids: cardiovascular benefits, sources and sustainability.
    Lee JH; O'Keefe JH; Lavie CJ; Harris WS
    Nat Rev Cardiol; 2009 Dec; 6(12):753-8. PubMed ID: 19859067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2018 Aug; 17(1):119. PubMed ID: 30153832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?
    Maki KC; Dicklin MR
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29973554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Jaca A; Durão S; Harbron J
    S Afr Med J; 2020 Nov; 110(12):1158-1159. PubMed ID: 33403957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?
    Rizos EC; Elisaf MS
    Curr Cardiol Rep; 2017 Jun; 19(6):47. PubMed ID: 28432658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Siscovick DS; Barringer TA; Fretts AM; Wu JH; Lichtenstein AH; Costello RB; Kris-Etherton PM; Jacobson TA; Engler MB; Alger HM; Appel LJ; Mozaffarian D;
    Circulation; 2017 Apr; 135(15):e867-e884. PubMed ID: 28289069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials.
    Wang Q; Liang X; Wang L; Lu X; Huang J; Cao J; Li H; Gu D
    Atherosclerosis; 2012 Apr; 221(2):536-43. PubMed ID: 22317966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Omega-3 polyunsaturated fatty acids and cardiovascular diseases].
    Marchioli R
    Minerva Cardioangiol; 2003 Oct; 51(5):561-76. PubMed ID: 14551524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids: role in cardiovascular health and disease.
    Engler MM; Engler MB
    J Cardiovasc Nurs; 2006; 21(1):17-24, quiz 25-6. PubMed ID: 16407732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.
    de Bree A; Mennen LI; Hercberg S; Galan P
    Eur J Clin Nutr; 2004 May; 58(5):732-44. PubMed ID: 15116076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-6 and omega-3 fatty acids: partners in prevention.
    Harris W
    Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):125-9. PubMed ID: 20145438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors.
    Mori TA
    Food Funct; 2014 Sep; 5(9):2004-19. PubMed ID: 25062404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved.
    Watanabe Y; Tatsuno I
    J Atheroscler Thromb; 2020 Mar; 27(3):183-198. PubMed ID: 31582621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future.
    Watanabe Y; Tatsuno I
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):865-873. PubMed ID: 28531360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of omega-3 polyunsaturated fatty acids in cardiovascular health.
    Barrett SJ
    Altern Ther Health Med; 2013; 19 Suppl 1():26-30. PubMed ID: 23981464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 (n-3) fatty acids in health and disease: Part 1--cardiovascular disease and cancer.
    Shahidi F; Miraliakbari H
    J Med Food; 2004; 7(4):387-401. PubMed ID: 15671680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.